|
|
||||||||
J Thorac Cardiovasc Surg 2004;127:1840-1843
© 2004 The American Association for Thoracic Surgery
Brief communication |
a Department of Thoracic Surgery, University of Torino, Torino, Italy
b Division of General Surgery, University of Torino, Torino, Italy,
c Department of Human Oncology and Biomedical Sciences, University of Torino, Torino, Italy
Received for publication February 11, 2003; accepted for publication March 12, 2003.
* Address for reprints: Pier Luigi Filosso, MD, University of Torino, San Giovanni Battista Hospital, Via Genova, 3, Torino 10126, Italy
pierluigifilosso@tiscalinet.it
| The first 20% of the full text of this article appears below. |
Bronchial carcinoids (BCs) are rare and constitute less than 2% of pulmonary tumors.1 They are characterized by slow, mainly endobronchial growth, with infrequent regional lymph node involvement or distant metastases.2
Atypical carcinoids are part of the spectrum of neuroendocrine bronchopulmonary tumors, according to the 1999 World Health OrganizationInternational Association for the Study of Lung Cancer (WHO-IASLC) Lung Tumor classification.3 They present 2 low-grade (typical and atypical carcinoids) and 2 high-grade malignant varieties (large cell neuroendocrine carcinoma and small cell lung carcinoma), the latter characterized by a high tendency toward mediastinal and distant metastatic spread.
Among low-grade malignant tumors, atypical carcinoids show a more aggressive biologic behavior than typical carcinoids4: mediastinal lymph node metastases occur at presentation in about 15% of cases. Distant metastases are generally in the liver and in the bone.
We present a case of a woman in whom thyroid metastasis occurred 30 months after the resection of an atypical BC.
Clinical summary
A 53-year-old white woman was referred to us in June 1999 because of the presence of a large pulmonary mass (7 x 3 cm in size) in the right lower lobe. The lesion had been detected with chest radiography performed in July 1998, and it was 5 x 2 cm in size, but at that time, the patient refused the intervention. She eventually agreed to be operated on because of the progression of the lesion and the associated cough and dyspnea. A preoperative transthoracic fine-needle aspiration biopsy was performed, and neoplastic cells with neuroendocrine features were observed. 111In-DTPA-Pentetreotide scintigraphy (Octreoscan) was performed for a correct preoperative assessment, resulting in an elective uptake in correspondence of the pulmonary lesion with no other abnormal uptakes. Chromogranin A and neuron-specific enolase serum levels were performed and increased: 197 ng/mL (normal
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |